$0.645
+0.004 (+0.59%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de OTLK por análisis de gráficos similares
Alphio's OTLK stock price prediction model matches the current Outlook Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.65 (+0.12%). The 1-week path is $0.65 (+1.02%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Outlook Therapeutics Inc?
Outlook Therapeutics Inc (OTLK) is not a strong buy right now due to its current price of $0.6449 and a low RSI of 32.554, indicating oversold conditions. The company has recently received FDA approval for its drug LYTENAVA, which could potentially generate over $500 million in annual sales by 2030, but it also reported a significant net loss of $20.3 million for Q3 2026. The stock has a forward P/E of 2.8498, suggesting potential undervaluation, but the high volatility and negative sentiment surrounding the stock create considerable risk.
OTLK cerró en $0.64 el Friday, tras subir +0.59%
Outlook Therapeutics Inc (OTLK) last closed at $0.6449, gaining +0.59%. These facts feed the 1-day and 1-week OTLK price prediction above.
Factores de la previsión
Los factores de la previsión de Outlook Therapeutics Inc (OTLK) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de OTLK, ordenadas por similitud.
Análisis de estacionalidad de OTLK
Historically the probability of a positive August return for OTLK is 40.62%. July offers the highest probability of a positive month at 66.67%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.